[1]
Ramasco Rueda, F. 2010. Piperacilina tazobactan en monoterapia no es adecuado para la peritonitis postoperatoria: Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse JP, Valin N, Desmonts JM, Montravers P. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Critical Care 2010; 14: R20. Revista Electrónica AnestesiaR. 2, 10 (oct. 2010), 2. DOI:https://doi.org/10.30445/rear.v2i10.536.